Study of Macronutrients and Heart Disease Risk
MACRO
Macronutrient Composition of Diet and Risk Factors for Cardiovascular Disease
1 other identifier
interventional
148
1 country
1
Brief Summary
The objective of this trial is to examine the long-term effects of a diet low in carbohydrates, as compared to one low in fat, on cardiovascular disease risk factors, including blood pressure (BP), body weight and composition, serum lipids, plasma glucose, insulin, adipocytokines (adiponectin, leptin, resistin), and C-reactive protein (CRP) among obese adults. The investigators will test the following hypotheses: Hypothesis 1: Compared to a low fat diet, a diet low in carbohydrates will reduce systolic and diastolic BP over 12 months; Hypothesis 2: Compared to a low fat diet, a diet low in carbohydrates will reduce body weight, total percent body fat, and waist circumference over 12 months; Hypothesis 3: Compared to a low fat diet, a diet low in carbohydrates will reduce serum levels of LDL-cholesterol and triglycerides and increase serum levels of HDL-cholesterol over 12 months; Hypothesis 4: Compared to a low fat diet, a diet low in carbohydrates will reduce plasma levels of glucose and insulin levels over 12 months; and Hypothesis 5: Compared to a low fat diet, a diet low in carbohydrates will reduce plasma levels of leptin, resistin, and CRP and increase plasma levels of adiponectin over 12 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable obesity
Started Jan 2008
Longer than P75 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2008
CompletedFirst Submitted
Initial submission to the registry
January 24, 2008
CompletedFirst Posted
Study publicly available on registry
February 7, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2012
CompletedResults Posted
Study results publicly available
November 19, 2018
CompletedNovember 19, 2018
April 1, 2018
3 years
January 24, 2008
April 7, 2017
April 25, 2018
Conditions
Outcome Measures
Primary Outcomes (16)
Predicted Mean Difference in Body Weight From Baseline, by Assigned Dietary Group
Predicted mean difference from random-effects models that included diet, time, and diet-by-time interaction term. Markov-chain Monte Carlo techniques were used to impute missing values.
12 months
Predicted Mean Differences in Lean Mass From Baseline, by Assigned Dietary Group
Mean Difference in Lean Mass predicted from random-effects models that included diet, time, and diet-by-time interaction term. Markov-chain Monte Carlo techniques were used to impute missing values.
12 months
Predicted Mean Differences in Fat Mass From Baseline, by Assigned Dietary Group
Mean Difference in Fat Mass predicted from random-effects models that included diet, time, and diet-by-time interaction term. Markov-chain Monte Carlo techniques were used to impute missing values.
12 months
Predicted Mean Differences of Waist Circumference From Baseline, by Assigned Dietary Group
Predicted from random-effects models that included diet, time, and diet-by-time interaction term. Markov-chain Monte Carlo techniques were used to impute missing values.
12 months
Predicted Mean Differences in Total Cholesterol Level From Baseline by Assigned Dietary Group
Predicted from random-effects models that included diet, time, and diet-by-time interaction term. Markov-chain Monte Carlo techniques were used to impute missing values.
12 months
Predicted Mean Differences in LDL Cholesterol Level From Baseline, by Assigned Dietary Group
Predicted from random-effects models that included diet, time, and diet-by-time interaction term. Markov-chain Monte Carlo techniques were used to impute missing values.
12 months
Predicted Mean Differences in HDL Cholesterol From Baseline, by Assigned Dietary Group
Predicted from random-effects models that included diet, time, and diet-by-time interaction term. Markov-chain Monte Carlo techniques were used to impute missing values.
12 months
Predicted Mean Differences in Total-HDL Cholesterol Ratio From Baseline, by Assigned Dietary Group
Predicted from random-effects models that included diet, time, and diet-by-time interaction term. Markov-chain Monte Carlo techniques were used to impute missing values.
12 months
Predicted Mean Differences in Triglycerides From Baseline, by Assigned Dietary Group
Predicted from random-effects models that included diet, time, and diet-by-time interaction term. Markov-chain Monte Carlo techniques were used to impute missing values.
12 months
Predicted Mean Differences in Systolic Blood Pressure From Baseline, by Assigned Dietary Group
Predicted from random-effects models that included diet, time, and diet-by-time interaction term. Markov-chain Monte Carlo techniques were used to impute missing values.
12 months
Predicted Mean Difference in Diastolic Blood Pressure, by Assigned Dietary Group
Mean Difference in Diastolic Blood Pressure predicted from random-effects models that included diet, time, and diet-by-time interaction term. Markov-chain Monte Carlo techniques were used to impute missing values
12 Months
Predicted Mean Difference in Plasma Glucose Level, by Assigned Dietary Group
Mean Difference in Plasma Glucose Level predicted from random-effects models that included diet, time, and diet-by-time interaction term. Markov-chain Monte Carlo techniques were used to impute missing values.
12 months
Predicted Mean Differences in Serum Insulin Level From Baseline, by Assigned Dietary Group
Mean Difference in Serum Insulin Level predicted from random-effects models that included diet, time, and diet-by-time interaction term. Markov-chain Monte Carlo techniques were used to impute missing values.
12 months
Predicted Mean Differences in C-reactive Protein Level From Baseline, by Assigned Dietary Group
Mean Difference in C-reactive Protein Level predicted from random-effects models that included diet, time, and diet-by-time interaction term. Markov-chain Monte Carlo techniques were used to impute missing values
12 Months
Predicted Mean Differences in Serum Creatinine Level From Baseline, by Assigned Dietary Group
Mean Difference in Serum Creatinine Level predicted from random-effects models that included diet, time, and diet-by-time interaction term. Markov-chain Monte Carlo techniques were used to impute missing values.
12 Months
Predicted Mean Differences of 10-y Framingham Risk Score From Baseline, by Assigned Dietary Group
Mean Difference in 10-y Framingham Risk Score predicted from random-effects models that included diet, time, and diet-by-time interaction term. Markov-chain Monte Carlo techniques were used to impute missing values.
12 Months
Study Arms (2)
1
EXPERIMENTALlow carbohydrate diet
2
ACTIVE COMPARATORlow fat diet
Interventions
Eligibility Criteria
You may qualify if:
- Men or women aged 22 - 75 years, any race/ethnicity
- BMI of 30 - 45 k/m2
- Willing and able to provide informed consent
You may not qualify if:
- History of self-reported clinical CVD (angina/myocardial infarction, coronary revascularization, heart failure, stroke/transient ischemic attack, peripheral arterial disease)
- Medical condition in which a low-carbohydrate diet may not be advised (diabetes, renal disease, cancer requiring treatment during the past year, osteoporosis, untreated thyroid disease, gout)
- Current use of more than 2 antihypertensive or more than 2 cholesterol-lowering medications
- For women, current pregnancy or breastfeeding or plans to become pregnant during the study period
- Consumption of more than 21 alcoholic beverages per week
- Currently on a diet or using prescription weight loss medications, underwent weight loss surgery, and/or experienced weight loss \>15 pounds within 6 months of study entry
- Plans to move out of the study area (\>1 hour from study site) or difficulty to come to the study site
- Participation of another household member in the study; employees or persons living with employees of the study
- Participation in other lifestyle intervention trials currently
- At the discretion of the study coordinator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tulane University, Office of Health Research
New Orleans, Louisiana, 70112, United States
Related Publications (2)
Hu T, Yao L, Reynolds K, Niu T, Li S, Whelton P, He J, Bazzano L. The effects of a low-carbohydrate diet on appetite: A randomized controlled trial. Nutr Metab Cardiovasc Dis. 2016 Jun;26(6):476-88. doi: 10.1016/j.numecd.2015.11.011. Epub 2015 Dec 12.
PMID: 26803589DERIVEDBazzano LA, Hu T, Reynolds K, Yao L, Bunol C, Liu Y, Chen CS, Klag MJ, Whelton PK, He J. Effects of low-carbohydrate and low-fat diets: a randomized trial. Ann Intern Med. 2014 Sep 2;161(5):309-18. doi: 10.7326/M14-0180.
PMID: 25178568DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Lydia Bazzano
- Organization
- Tulane University
Study Officials
- PRINCIPAL INVESTIGATOR
Lydia A Bazzano, MD, PhD
Tulane University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor Epidemiology
Study Record Dates
First Submitted
January 24, 2008
First Posted
February 7, 2008
Study Start
January 1, 2008
Primary Completion
January 1, 2011
Study Completion
January 1, 2012
Last Updated
November 19, 2018
Results First Posted
November 19, 2018
Record last verified: 2018-04